Project Grant R01AI191110
Award Date
5/7/25
Completion Date
4/30/30
Dollars Obligated
$645K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
This Project Grant award of $832,910 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to identify immune signatures that predict cytomegalovirus (CMV) disease risk in orthotopic liver transplant recipients. The research aims to characterize the neutralizing and non-neutralizing antibody response, map the CMV-specific B cell repertoire, and quantify and analyze the CMV-specific T cell repertoire to...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $196,344 to Emory University to conduct research on identifying immune biomarkers that can predict outcomes in solid organ transplant patients with bloodstream infections. The key objectives are to: 1) identify cytokine, chemokine, and biomarkers associated with septic shock and 30-day mortality in these...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to evaluate the use of serum microRNA (miRNA) profiling to assist in the safe tapering of immunosuppression for liver transplant recipients. The $264,596 award will support a 3-phase study design to establish trial procedures, develop the protocol, and assess outcome measures. The research team, led by The...
This Project Grant award of $775,986 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) supports research conducted by Northwestern University to investigate methods for mitigating cytomegalovirus (CMV) reactivation in kidney transplant recipients. The key objectives are to determine whether targeting the cellular stress response pathways of endoplasmic reticulum stress (via IRE-1α) and mitochondrial dysfunction (via DRP1) can...
This Project Grant award of $612,975.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Pittsburgh. The award aims to develop a translatable model for inducing long-term organ transplant acceptance by combining T cell costimulation blockade with inhibition of monocyte allorecognition via CD47. The research will also investigate the mechanisms of monocyte...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,648,086 to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to conduct research on immune repertoire remodeling following B cell-targeted CAR T cells for the induction of renal allograft tolerance in non-human primates. The goal is to...
This Project Grant award for $327,500 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to better understand the role of the CD43 receptor on effector CD8+ T cells during acute allograft rejection. The key objectives are to: Define the effector mechanisms that distinguish CD43+ effector T cells from CD43- effector T cells, including their differentiation pathways, trafficking...
This Project Grant award, with a total funding amount of $210,867, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The funding will support research conducted by Drexel University to develop a cell-based therapy for generating donor-specific immune tolerance in kidney transplant recipients. The key products and services to be delivered under this grant include: Engineering...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $924,000 to New York Medical College to discover and characterize the first-in-world small molecule inhibitors of the Epstein-Barr virus (EBV) protein BPLF1, which has deubiquitinating activity. The award aims to use high-throughput screening to identify novel chemotypes for lead optimization and further validate...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $199,584 to Dr. Hyun Ah Yoon at the Albert Einstein College of Medicine to conduct research on antibody biomarkers for assessing risk of cryptococcosis in immunosuppressed solid organ transplant recipients. The key products and services to be delivered through this 5-year project include: 1) Retrospectively...